Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies

A recent report estimated the breast cancer risks in carriers of the three Ashkenazi founder mutations to be higher than previously published estimates derived from population based studies. In an attempt to confirm this, the breast and ovarian cancer risks associated with the three Ashkenazi founde...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Antoniou, A, Pharoah, P, Narod, S, Risch, H, Eyfjord, J, Hopper, J, Olsson, H, Johannsson, O, Borg, A, Pasini, B, Radice, P, Manoukian, S, Eccles, D, Tang, N, Olah, E, Anton-Culver, H, Warner, E, Lubinski, J, Gronwald, J, Gorski, B, Tulinius, H, Thorlacius, S, Eerola, H, Nevanlinna, H, Syrjakoski, K, Kallioniemi, O, Thompson, D, Evans, C, Peto, J, Lalloo, F, Evans, D, Easton, D
פורמט: Artigo
שפה:Inglês
יצא לאור: BMJ Group 2005
נושאים:
Letter to JMG
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC1736090/
https://ncbi.nlm.nih.gov/pubmed/15994883
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jmg.2004.024133
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים